Teva's ProAir Digihaler FDA Approved to Monitor Asthma and COPD Treatment - Basel St 5, Petah Tikva, Israel
Teva Pharmaceuticals receives European approval for Spiromax inhalers - Drug Delivery Business
Digital Inhaler With Built-In Sensors Wins FDA Approval | Everyday Health
Qvar 100 Autohaler (Teva UK Ltd) 200 dose - RightBreathe
Teva Pharmaceuticals Ireland today launches the first national respiratory inhaler recycling pilot
Teva and Styrolution team up to produce Spiromax dry powder inhaler
Teva Announces FDA approval of AirDuo® Digihaler™
Teva Pharmaceuticals Announces Launch of Daily Maintenance Asthma Medication | Asthma and Allergy Foundation of America
Teva's generic of AirDuo RespiClick® Inhalation Powder: Fluticasone Propionate and Salmeterol Inhalation Powder (Multidose Dry Powder Inhaler)
Teva launches AirDuo RespiClick and generic together - CDR – Chain Drug Review
Teva introduces QVAR RediHaler inhalation aerosol in US - Pharmaceutical Technology
FDA gives nod to pediatric use of Teva's ProAir RespiClick inhaler | FiercePharma
Capsule inhalation warning for tiotropium inhaler | MIMS online
Teva Launches Two Digital Inhalers in the U.S., AirDuo® Digihaler® (fluticasone propionate and salmeterol) Inhalation Powder and ArmonAir® Digihaler® (fluticasone propionate) Inhalation Powder | Business Wire